FTS UK public procurement

Aseptically Prepared Systemic Anti-Cancer Therapy Medicines

Mid South Essex NHS Foundation Trust

ActiveOCDS ID ocds-h6vhtk-051cde
Tender value£850,000,0000 awards · 0 contracts

01 Procurement

Tender overview

Updated 13 April 2026
Buyer
Mid South Essex NHS Foundation Trust
Status
Active
Procurement method
Open procedure
Category
goods
CPV classification
Not supplied
Tender period
Not supplied — 11 May 2026

Description

This framework agreement is for the supply of a range of aseptically prepared, batch manufactured systemic anti-cancer therapy drugs in ready-to-administer presentations and agreed dose bands. The framework agreement will also cover the manufacturing and supply of patient specific systemic anti-cancer therapy drugs, CIVAs, and provisions for stock inventory management and supply of compounded systemic anti-cancer therapy.

i

This page represents one OCDS contracting process. Notices can be revised over time. Values may be estimates, award values or contract values and should be read with their displayed stage and date.

02 Awards and contracts

Published award records

0 shown

No award object is present in this compiled process yet.

03 Organisations

Buyers, suppliers and other parties

2 parties
Buyer

Mid South Essex NHS Foundation Trust

Nether Mayne, Basildon, UKH37, SS16 5NL, United Kingdom

GB-NHS RAJ
ProcuringEntity, ProcessContactPoint

HealthTrust Europe LLP

19 George Road, Birmingham, UKG31, B15 1NU, United Kingdom

Companies House OC358224 →

Companies House links appear only for explicit GB-COH identifiers. BritDB does not create company links from a similar name or address.

04 Provenance

Source for this process

Contains public sector information licensed under the Open Government Licence v3.0. Official external links are available only on the source transition page.